A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Bristol-Myers Squibb
Bristol-Myers Squibb
Verastem, Inc.
AstraZeneca
Phanes Therapeutics
Vanderbilt-Ingram Cancer Center
Cantargia AB
EMD Serono
Hoosier Cancer Research Network
Incyte Corporation
University of Texas Southwestern Medical Center
Bristol-Myers Squibb
Vanderbilt-Ingram Cancer Center